FOSUN MEDICAL SHANGHAI SCIENCE AND TECHNOLOGY I...

Company Description

Shanghai Fosun Medical system Co., Ltd, subsidiary to Shanghai Fosun Pharmaceutical (Group) Ltd (listed in Shanghai Stock Exchange stock No. 600196), focus on manufacturing, sales & marketing of Foshion brand medical instruments. Shanghai Science & Technology Imp. & Exp. Co., Ltd acts as fully authorized oversea sales & marketing platform. Focused on innovative medical instrument industry, Fosun Medical System has formed its core competences in R&D, marketing, M&A, and HR management after years of development, and now it is a large professional medical group, mainly in medical research and manufacturing, with leading market share in medical instruments distribution. At present, taking the advantage of the rapid growth of global medical industry, Fosun Medical System pushes forward its innovation, brand, cost and international strategies to realize its robust management & fast development. Looking forward to the future, Fosun Medical System will continue shouldering its social responsibilities, pay attention to the construction of personnel and working team, integrate medical industry resFOSUN MEDICAL SHANGHAI SCIENCE AND TECHNOLOGY I...ces, and finally improve its core competence and realize its strategic target of being a first-class enterprise in the global mainstream markets. History of Development 1959 factory established for sutures & blades 1968 factory established for blood transfusion products 1996 joint venture with Shanghai Blood Center 1998 factory for sutures & blades obtained ISO9002. 1998 patented virus-inactivated blood bag. 1999 factory for sutures & blades obtained â??TUVâ??&â??CEâ??ã??EN46002 2002 launch of second generation of virus inactivated blood bag. 2003 factory established for surgical workplace 2005 FDA approval for surgical sutures 2006 factory for blood transfusion obtained ISO9001 2007 TUV obtained for factory producing surgical table, light 2007 annual sales turnover of medical instrument department: 50million U.S. Dollars. 2008 operating lights obtained CE 2008, 5 2 million clinical trials for virus-inactivated blood bags.